ubmslateRN-logo-ubm

RN Mobile Menu

Search form

Topics:

Rheumatology Network

Research Roundup

Vaccine efficacy in rheumatoid arthritis, biosimilar safety and the danger of steroid injections for knee osteoarthritis top the research news roundup. In this slideshow, we feature these and other recent research findings. (©AdamGregor/Shutterstock.com)

Recent Content

Kevzara (Sarilumab). Photo courtesy of ©Sanofi, Regeneron.

The IL-6 inhibitor offers a monotherapy option for hard-to-treat rheumatoid arthritis cases.

(©Masycheva/Shutterstock.com)

Systemic sclerosis. Its rarity could lead to delays in diagnosis which, according to a review, may not be fully understood by inexperienced physicians.

(©Toa55/Shutterstock.com)

Study of long-term outcomes in rheumatoid arthritis supports early window of opportunity treatment theory.

(Injection of a vaccine  ©thodonal88/Shutterstock.com)

Vaccine efficacy in RA, biosimilar safety and the danger of steroid injections for knee osteoarthritis top this week's research roundup. In this slideshow, we feature these and other recent research findings from the key journals.

(©KPG_Payless/Shutterstock.com)

Clinical trial shows that switching from the infliximab originator to its biosimilar does not compromise safety or effectiveness of treatment.

(©Narikan/Shutterstock.com)

A Lyme arthritis diagnosis requires a two-step testing approach. False positives are complex and common.

Knee OA (©PuwadolJaturawutthichai/Shutterstock.com)

Despite monthly dosing regimen and long half-life of fulranumab, patients experienced pain relief within a short period of time.

By clicking Accept, you agree to become a member of the UBM Medica Community.